A detailed history of Jpmorgan Chase & CO transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Jpmorgan Chase & CO holds 500,723 shares of RDY stock, worth $7.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
500,723
Previous 638,758 21.61%
Holding current value
$7.17 Million
Previous $48.7 Million 18.26%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$75.41 - $84.21 $10.4 Million - $11.6 Million
-138,035 Reduced 21.61%
500,723 $39.8 Million
Q2 2024

Aug 12, 2024

BUY
$68.26 - $76.19 $25.8 Million - $28.8 Million
378,655 Added 145.58%
638,758 $48.7 Million
Q1 2024

May 10, 2024

BUY
$67.36 - $77.59 $15.1 Million - $17.4 Million
223,861 Added 617.68%
260,103 $19.1 Million
Q4 2023

Feb 12, 2024

BUY
$64.27 - $69.9 $142,486 - $154,968
2,217 Added 6.52%
36,242 $2.52 Million
Q3 2023

Nov 14, 2023

SELL
$61.9 - $72.77 $1.86 Million - $2.19 Million
-30,029 Reduced 46.88%
34,025 $2.28 Million
Q2 2023

Aug 11, 2023

BUY
$53.34 - $63.11 $2.63 Million - $3.12 Million
49,385 Added 336.66%
64,054 $4.04 Million
Q1 2023

May 11, 2023

SELL
$51.63 - $56.93 $173,838 - $191,683
-3,367 Reduced 18.67%
14,669 $835,000
Q4 2022

Feb 13, 2023

SELL
$51.15 - $57.45 $16.2 Million - $18.2 Million
-316,168 Reduced 94.6%
18,036 $933,000
Q3 2022

Nov 14, 2022

BUY
$49.9 - $57.32 $2.62 Million - $3.01 Million
52,535 Added 18.65%
334,204 $17.5 Million
Q2 2022

Aug 11, 2022

SELL
$49.62 - $58.13 $11.1 Million - $13 Million
-222,786 Reduced 44.16%
281,669 $15.6 Million
Q1 2022

May 11, 2022

BUY
$48.27 - $65.25 $17.5 Million - $23.7 Million
363,306 Added 257.39%
504,455 $28.1 Million
Q4 2021

Feb 10, 2022

SELL
$59.5 - $67.25 $3.45 Million - $3.9 Million
-57,984 Reduced 29.12%
141,149 $9.23 Million
Q3 2021

Nov 12, 2021

BUY
$60.19 - $75.29 $12 Million - $15 Million
199,133 New
199,133 $13 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.38B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.